Blocking the CD47-SIRPα Axis enhances Tafasitamab-mediated phagocytosis

被引：0

作者：

Biedermann, A. ^{[1
]}

Mangelberger-Eberl, D. ^{[2
]}

Mougiakakos, D. ^{[3
]}

Buettner-Herold, M. ^{[4
]}

Patra-Kneuer, M. ^{[2
]}

Flamann, C. ^{[1
]}

Kellner, C. ^{[5
]}

Peipp, M. ^{[6
]}

Altmeyer, S. ^{[7
]}

Bittenbring, J. ^{[7
]}

Augsberger, C. ^{[2
]}

Landgraf, K. ^{[2
]}

Ilieva-Babinsky, K. ^{[2
]}

Hasskamp, S. ^{[8
,9
]}

Beier, F. ^{[10
]}

Lischer, C. ^{[11
]}

Vera, J. ^{[11
]}

Voelkl, S. ^{[1
]}

Jacobs, B. ^{[1
]}

Steidl, S. ^{[2
]}

Heitmueller, C. ^{[2
]}

Mackensen, A. ^{[1
]}

Bruns, H. ^{[1
]}

机构：

[1] Friedrich Alexander Univ Erlangen Nurnberg, Dept Internal Med Hematol & Oncol 5, Erlangen, Germany

[2] MophoSys AG, Munich, Germany

[3] Otto von Guericke Univ, Dept Hematol & Oncol, Magdeburg, Germany

[4] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephropathol, Erlangen, Germany

[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Div Transfus Med Cell Therapeut & Haemostaseol, Munich, Germany

[6] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Kiel, Germany

[7] Saarland Univ, Med Klin 1, Med Sch, Homburg, Germany

[8] Friedrich Alexander Univ Erlangen Nurnberg, Erlangen, Germany

[9] Inst Human Genet, Erlangen, Germany

[10] RWTH Med Sch, Dept Oncol Hematol & Stem Cell Transplantat, Aachen, Germany

[11] Friedrich Alexander Univ Erlangen Nurnberg, Dept Dermatol, Erlangen, Germany

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P762

引用

页码：269 / 269

页数：1

共 50 条

[21] CD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategies
Bouwstra, Renee
van Meerten, Tom
Bremer, Edwin
CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (08):
[22] Glutaminyl cyclase is an enzymatic modifier of the CD47-SIRPα axis and a target for cancer immunotherapy
Logtenberg, Meike E. W.
Jansen, J. H. Marco
Raaben, Matthijs
Toebes, Mireille
Franke, Katka
Brandsma, Arianne M.
Matlung, Hanke L.
Fauster, Astrid
Gomez-Eerland, Raquel
Bakker, Noor A. M.
van der Schot, Simone
Marijt, Koen A.
Verdoes, Martijn
Haanen, John B. A. G.
van den Berg, Joost H.
Neefjes, Jacques
van den Berg, Timo K.
Brummelkamp, Thijn R.
Leusen, Jeanette H. W.
Scheeren, Ferenc A.
Schumacher, Ton N.
NATURE MEDICINE, 2019, 25 (04) : 612 - +
[23] Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma
Zhang, Xuyao
Chen, Wei
Fan, Jiajun
Wang, Shaofei
Xian, Zongshu
Luan, Jingyun
Li, Yubin
Wang, Yichen
Nan, Yanyang
Luo, Man
Li, Song
Tian, Wenzhi
Ju, Dianwen
CARCINOGENESIS, 2018, 39 (05) : 689 - 699
[24] Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma
Hutter, Gregor
Theruvath, Johanna
Graef, Claus Moritz
Zhang, Michael
Schoen, Matthew Kenneth
Manz, Eva Maria
Bennett, Mariko L.
Olson, Andrew
Azad, Tej D.
Sinha, Rahul
Chang, Carmel
Kahn, Suzana Assad
Gholamin, Sharareh
Wilson, Christy
Grant, Gerald
He, Joy
Weissman, Irving L.
Mitra, Siddhartha S.
Cheshier, Samuel H.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (03) : 997 - 1006
[25] The research of CD47-SIRPα interaction functional epitope
Wang, Z.
Luo, L.
Qiao, C.
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1260 - 1260
[26] Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model
Lysenko, Veronika
Schurch, Patrick M.
Tuzlak, Selma
van Wijk, Nicole Wildner-Verhey
Kovtonyuk, Larisa V.
Becher, Burkhard
Manz, Markus G.
Kreutmair, Stefanie
Theocharides, Alexandre P. A.
LEUKEMIA, 2023, 37 (06) : 1277 - 1286
[27] Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis
Hendriks, Mark A. J. M.
Britsch, Isabel
Ke, Xiurong
van Wijngarden, Anne P.
Samplonius, Douwe F.
Ploeg, Emily M.
Helfrich, Wijnand
ONCOIMMUNOLOGY, 2021, 10 (01):
[28] Human SIRPα expression by porcine LSEC overcomes CD47-SIRPα species incompatibilities reducing human platelet phagocytosis in vitro
Paris, Leela L.
Reyes, Luz M.
Chihara, Ray K.
Sidner, Richard A.
Blankenship, Ross L.
Downey, Susan M.
Tector, A. Joseph
HEPATOLOGY, 2013, 58 : 376A - 377A
[29] Antibody blockade of CD47-SIRPα axis is protective in the murine model of Experimental Autoimmune Encephalomyelitis
Velazquez, Francisco E.
Autio, Anu
Newton, Gail
Luscinskas, Francis William
FASEB JOURNAL, 2019, 33
[30] Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model
Veronika Lysenko
Patrick M. Schürch
Selma Tuzlak
Nicole Wildner-Verhey van Wijk
Larisa V. Kovtonyuk
Burkhard Becher
Markus G. Manz
Stefanie Kreutmair
Alexandre P. A. Theocharides
Leukemia, 2023, 37 : 1277 - 1286

← 1 2 3 4 5 →